Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stephen Heisler

Podiatrist, Foot & Ankle Surgery Chapel Hill, NC Doctor of Podiatric Medicine

NPI 1710360953 CMS profile 1331758

300 Meadowmont Village Cir Ste 301, Chapel Hill, NC 27517

Open in the dashboard

General payments

$49,414

81 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$475,315 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Stephen Heisler of Chapel Hill, NC is reported in the CMS Open Payments database as having received $49,414 across 81 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $475,315 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,305 27
2024 General $20,631 23
2023 General $6,733 12
2022 General $2,317 5
2021 General $21 1
2020 General $951 2
2019 General $1,456 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Heisler
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Stephen Heisler were reported at $17,305. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Stephen Heisler Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $1,456 $389 $118–$1,406 $163
2020 $951 $191 $62–$691 $114
2021 $21 $329 $104–$1,341 $132
2022 $2,317 $419 $125–$1,611 $149
2023 $6,733 $377 $128–$1,164 $160
2024 $20,631 $394 $134–$1,168 $164
2025 $17,305 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. RedDress USA, Inc. $22,930 28 payments
  2. LifeNet Health $19,606 29 payments
  3. Bioventus LLC $2,127 2 payments
  4. Arteriocyte Medical Systems, Inc. $1,800 1 payment
  5. SouthTech Orthopedics $1,534 5 payments
  6. Arthrex, Inc. $641 6 payments
  7. Acera Surgical, Inc. $258 2 payments
  8. Tactile Systems Technology Inc $188 1 payment
  9. Integra LifeSciences Corporation $175 1 payment
  10. PolyMedics Innovations Inc $59 1 payment
  11. Other $97 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $38,528 15 payments
  2. Travel and Lodging $4,490 15 payments
  3. Food and Beverage $2,394 46 payments
  4. Education $2,003 4 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,000 1 payment
Products named General payments · program years 2019–2025
  1. TheraGenesis Wound Matrix $19,606 29 payments
  2. ActiGraft $6,278 5 payments
  3. InFlux $1,800 1 payment
  4. Restrata Wound Matrix $258 2 payments
  5. FLEXITOUCH $188 1 payment
  6. ACTITOUCH $188 1 payment
  7. ENTRE $188 1 payment
  8. Integra Recon-Skin And Wound $175 1 payment
  9. Integra Recon-Skin And Wound $175 1 payment
  10. Integra Recon-Skin And Wound $175 1 payment
  11. Other $600 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

152

Median for Podiatry: 160

Drug cost

$1,785

Median for Podiatry: $2,368

Branded share of claims

25.7%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 43 $544
Cephalexin Generic 19 $321
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 27 $271
Ciprofloxacin Hcl Generic 19 $248
Gabapentin Generic 12 $237
Oxycodone Hcl Generic 20 $83
Ssd Silver Sulfadiazine Brand 12 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$40,261

Medicare's payments for the services billed

Medicare patients

95

Average age 70

Services billed

610

37 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Diabetes 75%
High blood pressure 75%
Arthritis 72%
Chronic kidney disease 64%
Heart failure 53%
Ischemic heart disease 52%
Depression 41%
Atrial fibrillation 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record